Discussion
A new U.S. study has found that use of the recombinant zoster vaccine effectively reduces the risk of herpes zoster — more commonly known as shingles — in adults with multiple sclerosis (MS). Specifically, in a retrospective analysis involving more than 14,000 vaccinated people with MS, receiving the recombinant…